This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.

The Epoch Times
The Epoch Times
Focus

Merck & Co

LATEST

US
US
|
Reuters

FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment

Jul 28, 2021
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
FDA Approves Merck’s Keytruda Combo for Early Breast Cancer Treatment
Jul 28
|
FacebookXTruthGettrLinkedInTelegramEmail
US News
US News
|
Reuters

Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment

Dec 23, 2020
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
Merck Signs $356 Million US Supply Deal for Its Experimental COVID-19 Treatment
Dec 23
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.